| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -14.13M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DMAC returned +4.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -20.0% |
| 1 year | +4.3% |
| 5 years | +48.1% |
| 10 years | +61.5% |
| All-time high | $37.98 (Sep 2012) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DMAC would be worth today ›No. DiaMedica Therapeutics Inc. has not paid a dividend in the past 12 months.
DiaMedica Therapeutics Inc. stock trades on NASDAQ under the ticker symbol DMAC.
DiaMedica Therapeutics Inc. is part of the Healthcare sector.
DiaMedica Therapeutics Inc. has a market cap of 343.51M USD, based on the latest quote.
DiaMedica Therapeutics Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
